Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Health & Biotech
Health Check: Sonic Healthcare is cashed up and ready to boom as earnings improve
Health & Biotech
Health Check: Hearts aflutter as Echo IQ aces deal with major US teaching hospital
Health & Biotech
Health Check: Actinogen powers ahead with key Alzheimer’s disease trial
Health & Biotech
Scott Power: ACCC’s approval of Sigma, Chemist Warehouse union turned heads this week
News
Closing Bell: ASX up as traders dump MinRes; Ordell jumps on standout gold drill results
Health & Biotech
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
News
Closing Bell: Telix, banks lift ASX; but Newmont and Fortescue trip over soaring costs
Health & Biotech
Health Check: Approval clock ticks as FDA accepts Telix’s brain diagnostic marketing application
News
Closing Bell: Miners lead ASX; Renu Energy spikes on hydrogen offer; WEB plunges over 30pc
News
ASX Small Caps Lunch Wrap: Local benchmarks take cue from Wall Street
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Health & Biotech
Health Check: Island Pharmaceuticals raises funds to put the mozz on dengue fever outbreak
Health & Biotech
Health Check: Probiotics supplier has gut feeling about surging growth
Health & Biotech
Broker Upgrades: Earnings season reveals gems, and Telix and CSL are ones to watch
News
